News & Perspective

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

(CIDRAP News) – The German Ministry of Food, Agriculture & Consumer Protection (BMELV) today announced that it has agreed to host the influenza gene sequence database of the Global Initiative on Sharing All Influenza Data (GISAID), putting its future on a more solid footing as the world enters the second wave of the H1N1 flu pandemic.

(CIDRAP News) – With so much uncertainty over how broad and severe the next wave of H1N1 influenza could be, now is the time to focus on the two top goals of saving and sustaining lives, Dr. Julie Gerberding, former director of the US Centers for Disease Control and Prevention (CDC), told business groups today.